Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis
Cancer Growth and Metastasis · 2014
DOI: 10.4137/cgm.s14501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Growth and Metastasis, 2014. Verfasst von Patrick C Hackler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Pro-oxidative stressors including cigarette smoke (CS) generate novel lipids with platelet-activated factor-receptor (PAF-R) agonistic activity mediate systemic immunosuppression, one of the most recognized events in promoting carcinogenesis. Our previous studies have established that these oxidized-PAF-R-agonists augment murine B16F10 melanoma tumor growth in a PAF-R-dependent manner because of its effects on host immunity. As CS generates PAF-R agonists, the current studies sought to determine the impact of PAF-R agonists on lung cancer growth and metastasis. Using the murine Lewis Lung Carcinoma (LLC1) model, we demonstrate that treatment of C57BL/6 mice with a PAF-R agonist augments tumor growth and lung metastasis in a PAF-R-dependent manner as these findings were not seen in PAF-R-deficient mice. Importantly, this effect was because of host rather than tumor cells PAF-R dependent as LLC1 cells do not express functional PAF-R. These findings indicate that experimental lung cancer progression can be modulated by the PAF system.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA.
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
- Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA. ; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. ; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA. ;…
Förderung
- NIEHS NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Hackler, P. C., Reuss, S., Konger, R. L., Travers, J. B., & Sahu, R. P. (2014). Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis. Cancer Growth and Metastasis. https://doi.org/10.4137/cgm.s14501
Vancouver
Hackler PC, Reuss S, Konger RL, Travers JB, Sahu RP. Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis. Cancer Growth and Metastasis. 2014. doi:10.4137/cgm.s14501
BibTeX
@article{Hackler2014,
author = {Hackler, Patrick C and Reuss, Sarah and Konger, Raymond L and Travers, Jeffrey B and Sahu, Ravi P},
title = {Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis},
journal = {Cancer Growth and Metastasis},
year = {2014},
doi = {10.4137/cgm.s14501}
}
EUVIMED